Skip to main content

Table 3 Distribution of percent differences between malaria commodity stock levels reported through the routine malaria information system compared to those verified during four end-user verification surveys, Guinea

From: Evaluating the quality of routinely reported data on malaria commodity stocks in Guinea, 2014–2016

Commodity

Number of reports

< 25% difference

25–50% difference

> 50% difference

RDT

37/92 (40%)

15/92 (16%)

40/92 (43%)

ASAQ infant

47/93 (51%)

11/93 (12%)

35/93 (38%)

ASAQ small child

47/99 (47%)

13/99 (13%)

39/99 (39%)

ASAQ child

44/102 (43%)

17/102 (17%)

41/102 (40%)

ASAQ adult

40/98 (41%)

22/98 (22%)

36/98 (37%)

AL

4/15 (27%)

4/15 (27%)

7/15 (47%)

SP

40/98 (41%)

17/98 (17%)

41/98 (42%)

Injectable artesunate

4/9 (44%)

2/9 (22%)

3/9 (33%)

Injectable artemether

4/10 (40%)

0/10 (0%)

6/10 (60%)

Injectable quinine

31/74 (42%)

18/74 (24%)

25/74 (34%)

Quinine tablets

20/53 (38%)

6/53 (11%)

27/53 (51%)

LLIN

25/53 (47%)

11/53 (21%)

17/53 (32%)

  1. RDT Rapid diagnostic test, ASAQ artesunate–amodiaquine, AL artemether–lumefantrine, SP sulfadoxine–pyrimethamine, LLIN long-lasting insecticidal net